-
Zhu Rongji, trailblazing ex-premier who transformed China's economy
-
WHO says Trump vaccine shake-up goes against evidence
-
China tech giant Tencent's Q2 profit down as AI push builds
-
Eclipse chasers flock to Spain for 'breathtaking' experience
-
China's C919 jet makes first international commercial flight
-
'To make the civilians leave': Russia pummels Ukraine's petrol stations
-
Mideast war impact on travel bookings fading, TUI says
-
Japan brushes off Australian PM's melon drama
-
Bangladesh get Das fitness boost for daunting Australia task
-
Rod Stewart cancels tour dates after heart surgery
-
One dead, 172 rescued as second ferry in days catches fire in Indonesia
-
How Britain's mapmakers track climate change
-
Foxconn posts quarterly profit surge on AI server demand
-
Australian delivery drivers win 'world-leading' pay rise
-
Hazlewood gets Australia nod ahead of Boland for Bangladesh Test
-
Meta meets its own 'tobacco' moment in court
-
Toyota ex-chief Okuda, pioneer of the Prius, dead at 93
-
Art or medicine? Japan's cosmetic tattoo artists in limbo
-
Colombia rescuers find woman alive as quake death toll passes 200
-
Rybakina ousts Osaka to book Toronto semi-final against Gauff
-
New Zealand PM survives leadership challenge months from election
-
Colombia rescuers find woman alive as quake death toll passes 240
-
Passengers rescued as second ferry in days catches fire in Indonesia
-
Charges dropped against Bondi Beach attack hero
-
Oil prices rise, stocks mixed ahead of crucial US inflation data
-
Parched and desperate for rain, Kazakhstan turns to cloud-seeding
-
UK 'joke' candidate Binface pushes serious point about politics
-
The perfect storm that turbocharged Venezuela's twin quakes
-
New Zealand PM Luxon survives leadership challenge months from election
-
2.4 million girls banned from Afghan schools since Taliban return: UNESCO
-
Cuba celebrates Castro's 100th as his revolution faces its toughest test
-
Colombians dig through rubble as quake death toll surpasses 240
-
Defending champion Shelton rolls into Montreal semis
-
New Zealand's ruling party meets to decide PM Luxon's fate
-
What to know about the total solar eclipse
-
Total solar eclipse to spellbind Europe
-
Tentoglou claims fourth Euro long jump title, injured Jacobs falters
-
Jodar, Nakashima to make Masters semis debuts in Montreal
-
All Blacks knew Nonu would perform solo Haka - coach Rennie
-
Chilean veteran Sanchez signs with MLS club Montreal
-
Britain's Glave upstages Jacobs to win European 100m gold
-
Cristiano Ronaldo marries long-term partner Georgina Rodriguez
-
Greece's Tentoglou wins fourth European long jump title
-
Oil prices higher, stocks mixed ahead of inflation report
-
Doctors ignored 'warning signs' before Maradona's death, court hears
-
Jacobs into 100m final with eye on third title
-
Pereira, the 'zombie city' devastated by Colombia's earthquake
-
Eight-try New Zealand cruise to tour victory over Sharks
-
UN says 2 staff arrested by Afghan intelligence agency
-
Trump's secret plane swap triggers questions and confusion
E.coli can turn plastic into painkillers, chemists discover
Scientists have found a way to use the bacteria E.Coli to convert plastic waste into a popular painkiller, a study said Monday, though outside experts doubted the technique would make a dent in the fight against plastic pollution.
Paracetamol, which is one of the most commonly used drugs worldwide, is made from the derivatives of fossil fuels, often by Asia-based subcontractors using cheap, polluting methods that contribute to climate change.
The world is also facing an escalating crisis of plastic pollution, with countries set for another bruising round of negotiations in August in the hope of sealing an international treaty to reduce plastic waste.
The British team of researchers behind the new study sought to find a solution to the two problems by roping in a third -- E.coli, which is normally known for making people sick when they eat contaminated food.
First the chemists used a molecule derived from PET plastic, which is used in bottles and many other plastic products the world over, to spark a chemical reaction in a strain of E.coli.
This created a molecule they called PABA, according to the Nature Chemistry study, which was partly funded by drug firm AstraZeneca.
By genetically modifying the bacteria, the chemists were able to transform their molecule into acetaminophen, also known as paracetamol.
"This work demonstrates that PET plastic isn't just waste or a material destined to become more plastic -- it can be transformed by microorganisms into valuable new products, including those with potential for treating disease," lead study Stephen Wallace said in a statement.
Singaporean researchers not involved in the study praised how it combined synthetic and biological chemistry.
But "several practical considerations remain" to take this idea beyond the proof-of-concept stage, they wrote in a linked commentary in the journal Nature Chemistry.
The chemical reaction produces only a limited amount of PABA molecules, which "may be insufficient for industrial applications", they wrote.
Melissa Valliant, communications director of the Beyond Plastics project of Bennington College in the United States, expressed scepticism.
"A new 'plastic-eating bacteria' pops up in the news every few months and has been doing so for years," she told AFP.
"These discoveries never scale up to anything significant enough to tackle the massive plastic pollution problem."
This "crisis needs to be stopped at the source," she added, which means "companies and policymakers must reduce the amount of plastic being produced and used in the first place".
U.Maertens--VB